...
首页> 外文期刊>Current opinion in gastroenterology >Rotavirus vaccines and intussusception risk
【24h】

Rotavirus vaccines and intussusception risk

机译:轮状病毒疫苗和肠套叠风险

获取原文
获取原文并翻译 | 示例
           

摘要

The association between Rotashield and the development of intussusception has presented a major challenge to the development of rotavirus vaccines. Intussusception risk is greatest in the first 3 to 14 days following the receipt of the first dose of Rotashield in infants older than 3 months of age. Although there continues to be debate surrounding the exact quantitation of risk of intussusception, it is accepted as a rare adverse event. The development of alternate rotavirus vaccines and emerging manufacturers in developing countries has renewed optimism for the reduction of the global burden of rotavirus disease.
机译:Rotashield和肠套叠的发展之间的关联已向轮状病毒疫苗的发展提出了重大挑战。在3个月以上的婴儿中,在接受第一剂Rotashield后的头3到14天内,肠套叠风险最高。尽管围绕肠套叠风险的确切定量方法仍存在争议,但它被认为是罕见的不良事件。轮状病毒替代疫苗的开发和发展中国家的新兴制造商对减少轮状病毒疾病的全球负担重新表示了乐观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号